| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/27/2005 | CA2528372A1 Inhibition of apoptosis-specific elf-5a ("eif-5a1") with antisense oligonucleotides and sirnas as anti-inflammatory therapeutics |
| 01/27/2005 | CA2525949A1 Transgenic cells expressing proteins involved in fatty acid biosynthesis |
| 01/27/2005 | CA2525825A1 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 01/27/2005 | CA2522508A1 Antisense antiviral agent and method for treating ssrna viral infection |
| 01/27/2005 | CA2516652A1 System for external control of oncolytic virus replication |
| 01/27/2005 | CA2499024A1 Membrane protein library for proteome analysis and method for preparing same |
| 01/26/2005 | EP1500705A1 Method of separating poly-3-hydroxyalkanoic acid |
| 01/26/2005 | EP1500704A1 Expression system of actinomycete-origin cytochrome p-450 in escherichia coli |
| 01/26/2005 | EP1500703A2 Human gaba receptors and polynucleotides encoding the same |
| 01/26/2005 | EP1500702A1 APO-2LI and APO-3 apoptosis polypeptides from the TNFR1 familiy |
| 01/26/2005 | EP1500701A1 Cancer-associated gene mina 53, protein mina 53 and monoclonal antibody thereof |
| 01/26/2005 | EP1500700A2 Pectic acid lyase |
| 01/26/2005 | EP1500699A1 Production of vaccinia virus with adherent or non adherent avian cell lines |
| 01/26/2005 | EP1500698A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 01/26/2005 | EP1500665A1 METHOD FOR CONSTRUCTING scDb LIBRARIES |
| 01/26/2005 | EP1500663A1 Secreted proteins and their uses |
| 01/26/2005 | EP1500400A1 Drug containing antibody composition |
| 01/26/2005 | EP1500399A1 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases |
| 01/26/2005 | EP1500329A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 01/26/2005 | EP1499895A2 Functionalized nanoparticles and methods of use |
| 01/26/2005 | EP1499889A2 Nanoparticle probes with raman spectroscopic fingerprints for analyte detection |
| 01/26/2005 | EP1499887A2 Universal libraries for immunoglobulins |
| 01/26/2005 | EP1499886A1 Methods and compositions for inducing an immune response |
| 01/26/2005 | EP1499885A2 Novel fusion proteins and assays for molecular binding |
| 01/26/2005 | EP1499748A1 Hepatitis c virus assay systems |
| 01/26/2005 | EP1499747A2 Formation and use of site specific nucleic acid coupled binding polypeptides |
| 01/26/2005 | EP1499746A1 Method to inhibit cell growth using oligonucleotides |
| 01/26/2005 | EP1499745A2 Characterization of single stranded nucleic acids by melting analysis of secondary structure using double strand-specific nucleic acid dye |
| 01/26/2005 | EP1499744A2 Process for detecting predisposition to a cardiovascular disease |
| 01/26/2005 | EP1499742A1 Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes |
| 01/26/2005 | EP1499739A2 Methods for increasing homologous recombination of a nucleic acid sequence |
| 01/26/2005 | EP1499738A2 Recombinase polymerase amplification |
| 01/26/2005 | EP1499736A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/26/2005 | EP1499735A2 Optimization of transgene expression in mammalian cells |
| 01/26/2005 | EP1499734A2 Process of producing environmentally safe transgenic organisms |
| 01/26/2005 | EP1499733A1 Methods for preparing variants of a dna sequence in filamentous fungi |
| 01/26/2005 | EP1499730A1 Immunoconjugates for the treatment of tumours |
| 01/26/2005 | EP1499729A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 01/26/2005 | EP1499728A2 Nucleotide sequence coding for a mannitol 2-dehydrogenase and method for the production of d-mannitol |
| 01/26/2005 | EP1499727A1 Hepatitis c virus replicon containing a reporter gene and a selectable marker gene |
| 01/26/2005 | EP1499726A1 Chimeric camp factors for vaccination against streptococcus infection |
| 01/26/2005 | EP1499725A1 Psp94 binding protein and psp94 diagnostic assays |
| 01/26/2005 | EP1499724A1 Derivatives of the il-2 receptor gamma chain, their production and use |
| 01/26/2005 | EP1499723A2 Novel nucleic acids and polypeptides |
| 01/26/2005 | EP1499722A2 Amplification vectors based on trans-splicing |
| 01/26/2005 | EP1499721A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription factors |
| 01/26/2005 | EP1499720A2 Gene targeting using replicating dna molecules |
| 01/26/2005 | EP1499719A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS |
| 01/26/2005 | EP1499718A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/26/2005 | EP1499716A1 Adh from rhodococcus erythropolis |
| 01/26/2005 | EP1499712A1 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 01/26/2005 | EP1499709A2 Promoter and plasmid system for genetic engineering |
| 01/26/2005 | EP1499708A1 A modified yeast consuming l-arabinose |
| 01/26/2005 | EP1499640A2 Immunoglobulin-domain containing cell surface recognition molecules |
| 01/26/2005 | EP1499638A2 Height-related gene |
| 01/26/2005 | EP1499637A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same |
| 01/26/2005 | EP1499633A2 Hagfish cathelin-associated antimicrobial peptides and genes |
| 01/26/2005 | EP1499631A2 Rna interference mediated inhibition of tgf-beta and tgf-beta receptor gene expression using short interfering nucleic acid (sina) |
| 01/26/2005 | EP1499630A2 Streptavidin expressed gene fusions and methods of use thereof |
| 01/26/2005 | EP1499628A2 Rna interference mediated inhibition of stearoyl-coa desaturase (scd) gene expression using short interfering nucleic acid (sina) |
| 01/26/2005 | EP1499627A2 Nuclease resistant chimeric oligonucleotides |
| 01/26/2005 | EP1499626A2 Solid phase methods for polynucleotide production |
| 01/26/2005 | EP1499441A1 System, substrate plate and incubation device for conducting biossays |
| 01/26/2005 | EP1499415A1 Structure and method for handling magnetic particles in biological assays |
| 01/26/2005 | EP1499362A1 Fusions of cytokines and tumor targeting proteins |
| 01/26/2005 | EP1499353A2 Antibodies that specifically bind to tl5 |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499351A2 Antibodies that specifically bind to tr2 |
| 01/26/2005 | EP1499350A2 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 01/26/2005 | EP1499349A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 01/26/2005 | EP1499348A2 Multi plasmid system for the production of influenza virus |
| 01/26/2005 | EP1499343A1 A method of modulating cellular activity |
| 01/26/2005 | EP1499332A2 Compositions and methods for treating cancer with an oncolytic viral agent |
| 01/26/2005 | EP1499327A2 Beta -amyloid peptide-binding proteins and polynucleotides encoding the same |
| 01/26/2005 | EP1499279A2 MOLECULES THAT MODULATE GaQ ACTIVITY AND METHODS OF TREATING URINARY INCONTINENCE |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | EP1499187A2 Immunostimulatory g,u-containing oligoribonucleotides |
| 01/26/2005 | EP1499182A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression |
| 01/26/2005 | EP1499180A2 Cancer models |
| 01/26/2005 | EP1499177A2 Transgenic plants with a suppressed triterpene level |
| 01/26/2005 | EP1499176A2 Novel vip3 toxins and methods of use |
| 01/26/2005 | EP1499175A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 01/26/2005 | EP1468094A4 Method of transducing es cells |
| 01/26/2005 | EP1440151A4 Seed specific 7s alpha promoter for expressing genes in plants |
| 01/26/2005 | EP1438331A4 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 01/26/2005 | EP1430140A4 Isoform-selective inhibitors and activators of pde3 cyclic |
| 01/26/2005 | EP1417344A4 Zinc finger domain libraries |
| 01/26/2005 | EP1390484A4 Methods for the identification of inhibitors of pectin esterase expression or activity in plants |
| 01/26/2005 | EP1385881A4 Anti-obesity polypeptides |
| 01/26/2005 | EP1383889A4 Modified organs and cells for xenotransplantation |
| 01/26/2005 | EP1335989A4 Method for generating recombinant polynucleotides |
| 01/26/2005 | EP1294921A4 Transgenically produced platelet derived growth factor |
| 01/26/2005 | EP1280901B1 3d structure of polypeptides containing a tpr-structure motif with chaperone-binding function, crystals thereof and compounds for inhibition of said peptides |
| 01/26/2005 | EP1257167A4 Production of mammals which produce progeny of a single sex |
| 01/26/2005 | EP1230377B1 Modulation of plant response to abscisic acid |
| 01/26/2005 | EP1198593B1 Amplification method for detection of target nucleic acids involving fluorescence energy transfer |
| 01/26/2005 | EP1185279B1 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication |
| 01/26/2005 | EP1152009B1 Novel nucleosides and oligonucleotide analogues |
| 01/26/2005 | EP1149158A4 Genetic and epigenetic regulation of abc transporters and ect0-phosphatases for the modulation of drug resistance |
| 01/26/2005 | EP1127133B1 Polypeptide mediating cell permeability |